Abstract
Voltage-dependent sodium channel complexes consist of a pore-forming and voltage-sensing α-subunit and one or two β-subunits. The latter are type I transmembrane proteins with a broad spectrum of functions in channel expression and surface targeting, in channel electrophysiology and, notably, in cell-adhesion of excitable and non-excitable cells. Like the amyloid-precursor protein (APP), β-subunits are substrates for sequential cleavage either by α- and γ-secretase, or by β- and γ-secretase. Here, we focus on the processing of β-subunits by the amyloidogenic β-secretase, BACE1, which is up-regulated in Alzheimers disease and is considered a highly promising pharmacologic target. Based on data from BACE1-deficient or over-expressing mice and from heterologous expression systems, this review summarizes our growing understanding of how BACE1-mediated cleavage of β-subunits interferes with their multiple physiological functions.
Keywords: BACE1, voltage-dependent sodium channel, -subunit, action potential, neuronal excitability, epilepsy, hippocampus, Alzheimer's disease, C-terminal fragment
Current Alzheimer Research
Title: Voltage-Dependent Na+ Channels as Targets of BACE1 - Implications for Neuronal Firing and Beyond
Volume: 9 Issue: 2
Author(s): Tobias Huth and Christian Alzheimer
Affiliation:
Keywords: BACE1, voltage-dependent sodium channel, -subunit, action potential, neuronal excitability, epilepsy, hippocampus, Alzheimer's disease, C-terminal fragment
Abstract: Voltage-dependent sodium channel complexes consist of a pore-forming and voltage-sensing α-subunit and one or two β-subunits. The latter are type I transmembrane proteins with a broad spectrum of functions in channel expression and surface targeting, in channel electrophysiology and, notably, in cell-adhesion of excitable and non-excitable cells. Like the amyloid-precursor protein (APP), β-subunits are substrates for sequential cleavage either by α- and γ-secretase, or by β- and γ-secretase. Here, we focus on the processing of β-subunits by the amyloidogenic β-secretase, BACE1, which is up-regulated in Alzheimers disease and is considered a highly promising pharmacologic target. Based on data from BACE1-deficient or over-expressing mice and from heterologous expression systems, this review summarizes our growing understanding of how BACE1-mediated cleavage of β-subunits interferes with their multiple physiological functions.
Export Options
About this article
Cite this article as:
Huth Tobias and Alzheimer Christian, Voltage-Dependent Na+ Channels as Targets of BACE1 - Implications for Neuronal Firing and Beyond, Current Alzheimer Research 2012; 9 (2) . https://dx.doi.org/10.2174/156720512799361619
DOI https://dx.doi.org/10.2174/156720512799361619 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intracellular and Extracellular Zinc Detection by Organic Fluorescent Receptor
Current Organic Chemistry An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design Common Issues Among Asthma, Epilepsy, and Schizophrenia: From Inflammation to Ca<sup>2+</sup>/cAMP Signalling
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
Current Medicinal Chemistry Molecular Mechanism of a Specific NLRP3 Inhibitor to Alleviate Seizure Severity Induced by Pentylenetetrazole
Current Molecular Pharmacology Strategic Aspects of NPY-Based Monoclonal Antibodies for Diagnosis and Treatment of Breast Cancer
Current Protein & Peptide Science Benzopentathiepine Derivative, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin- 6-Amine Hydrochloride (TC-2153), as a Promising Antidepressant of New Generation
Letters in Drug Design & Discovery Synthesis of Chromen-1-phenylpropan-1-one Derivatives and their Antidepressant/ Anticonvulsant Activities
Letters in Drug Design & Discovery Rethinking the Excitotoxic Ionic Milieu:The Emerging Role of Zn 2+ in Ischemic Neuronal Injury
Current Molecular Medicine Barbiturates: A Review of Synthesis and Antimicrobial Research Progress
Current Organic Synthesis Aspartate and Glutamate Mimetic Structures in Biologically Active Compounds
Current Medicinal Chemistry The DREAM of Pain Relief
Current Rheumatology Reviews In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Recent Patents on CNS Drug Discovery (Discontinued) Process Optimization for Extraction of Phytochemicals from <i>Ficus racemosa</i>: Phytochemical Extraction
The Natural Products Journal Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry Efficacy, Duration and Timing of Withdrawal of Prophylactic Treatment with Antiepileptic Drugs in Neurosurgical Conditions
Current Pharmaceutical Design Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets Targeting Cytokines for Morphine Tolerance: A Narrative Review
Current Neuropharmacology Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science Cancer Cell Permeability-Glycoprotein as a Target of MDR Reverters: Possible Role of Novel Dihydropyridine Derivatives
Current Drug Targets